389 related articles for article (PubMed ID: 32607945)
21. Itch Management: Topical Agents.
Metz M; Staubach P
Curr Probl Dermatol; 2016; 50():40-5. PubMed ID: 27578070
[TBL] [Abstract][Full Text] [Related]
22. Involvement of peripheral mu opioid receptors in scratching behavior in mice.
Yamamoto A; Sugimoto Y
Eur J Pharmacol; 2010 Dec; 649(1-3):336-41. PubMed ID: 20863827
[TBL] [Abstract][Full Text] [Related]
23. Therapy for pruritus in the elderly: a review of treatment developments.
Pereira MP; Ständer S
Expert Opin Pharmacother; 2018 Apr; 19(5):443-450. PubMed ID: 29493371
[TBL] [Abstract][Full Text] [Related]
24. Immunomodulating Agents as Antipruritics.
Erickson S; Nahmias Z; Rosman IS; Kim BS
Dermatol Clin; 2018 Jul; 36(3):325-334. PubMed ID: 29929604
[TBL] [Abstract][Full Text] [Related]
25. Role of kappa-opioid and mu-opioid receptors in pruritus: Peripheral and central itch circuits.
Kim BS; Inan S; Ständer S; Sciascia T; Szepietowski JC; Yosipovitch G
Exp Dermatol; 2022 Dec; 31(12):1900-1907. PubMed ID: 36054458
[TBL] [Abstract][Full Text] [Related]
26. Janus kinase inhibitor delgocitinib suppresses pruritus and nerve elongation in an atopic dermatitis murine model.
Yamamoto Y; Otsuka A; Nakashima C; Ishida Y; Honda T; Egawa G; Amano W; Usui K; Hamada Y; Wada M; Tanimoto A; Konishi N; Hayashi M; Matsushita M; Kabashima K
J Dermatol Sci; 2020 Feb; 97(2):161-164. PubMed ID: 31924380
[No Abstract] [Full Text] [Related]
27. Itch Management: General Principles.
Misery L
Curr Probl Dermatol; 2016; 50():35-9. PubMed ID: 27578069
[TBL] [Abstract][Full Text] [Related]
28. [Therapy for chronic pruritus-light at the end of a long tunnel?].
Pereira MP; Salzmann S; Ständer S; Staubach P; Metz M
Internist (Berl); 2020 Oct; 61(10):1076-1086. PubMed ID: 32676722
[TBL] [Abstract][Full Text] [Related]
29. Treatment of pruritus in early-stage hypopigmented mycosis fungoides with aprepitant.
Jiménez Gallo D; Albarrán Planelles C; Linares Barrios M; Fernández Anguita MJ; Márquez Enríquez J; Rodríguez Mateos ME
Dermatol Ther; 2014; 27(3):178-82. PubMed ID: 24517320
[TBL] [Abstract][Full Text] [Related]
30. Neurokinin 1 Receptor Antagonists for Pruritus.
Alam M; Buddenkotte J; Ahmad F; Steinhoff M
Drugs; 2021 Apr; 81(6):621-634. PubMed ID: 33675531
[TBL] [Abstract][Full Text] [Related]
31. Non-analgesic effects of opioids: peripheral opioid receptors as promising targets for future anti-pruritic therapies.
Reich A; Szepietowski JC
Curr Pharm Des; 2012; 18(37):6021-4. PubMed ID: 22747545
[TBL] [Abstract][Full Text] [Related]
32. Chronic pruritus in the absence of specific skin disease: an update on pathophysiology, diagnosis, and therapy.
Cassano N; Tessari G; Vena GA; Girolomoni G
Am J Clin Dermatol; 2010 Dec; 11(6):399-411. PubMed ID: 20866115
[TBL] [Abstract][Full Text] [Related]
33. Antipruritic activity of the kappa-opioid receptor agonist, TRK-820.
Togashi Y; Umeuchi H; Okano K; Ando N; Yoshizawa Y; Honda T; Kawamura K; Endoh T; Utsumi J; Kamei J; Tanaka T; Nagase H
Eur J Pharmacol; 2002 Jan; 435(2-3):259-64. PubMed ID: 11821035
[TBL] [Abstract][Full Text] [Related]
34. End-Stage Renal Disease Chronic Itch and Its Management.
Reszke R; Szepietowski JC
Dermatol Clin; 2018 Jul; 36(3):277-292. PubMed ID: 29929599
[TBL] [Abstract][Full Text] [Related]
35. Pruritus in Cutaneous T-Cell Lymphoma and Its Management.
Serrano L; Martinez-Escala ME; Zhou XA; Guitart J
Dermatol Clin; 2018 Jul; 36(3):245-258. PubMed ID: 29929596
[TBL] [Abstract][Full Text] [Related]
36. Current pharmaceutical developments in atopic dermatitis.
Misery L; Huet F; Gouin O; Ständer S; Deleuran M
Curr Opin Pharmacol; 2019 Jun; 46():7-13. PubMed ID: 30611103
[TBL] [Abstract][Full Text] [Related]
37. Antidepressants as antipruritic agents: A review.
Kaur R; Sinha VR
Eur Neuropsychopharmacol; 2018 Mar; 28(3):341-352. PubMed ID: 29456150
[TBL] [Abstract][Full Text] [Related]
38. [Opioid-induced pruritus].
Frost J; Spigset O
Tidsskr Nor Laegeforen; 2012 Oct; 132(19):2180-1. PubMed ID: 23076488
[TBL] [Abstract][Full Text] [Related]
39. Uremic Itch Management.
Mettang T
Curr Probl Dermatol; 2016; 50():133-41. PubMed ID: 27578082
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological Characterization of a Novel Mouse Model of Cholestatic Pruritus.
Andoh T; Suzuki K; Konno M; Tsuneyama K; Kuraishi Y
Biol Pharm Bull; 2020; 43(7):1111-1117. PubMed ID: 32612073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]